Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Cash Flow Reinvestment Rate
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting CN¥13.28 Million (capex CN¥13.28 Million ) from operating cash flow of CN¥103.70 Million. Check earnings quality score of Vcanbio Cell & Gene Engineering Corp Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vcanbio Cell & Gene Engineering Corp Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Vcanbio Cell & Gene Engineering Corp Ltd across 25 annual periods. Explore 600645 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Vcanbio Cell & Gene Engineering Corp Ltd. For live market cap and broader valuation context, see 600645 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.39x | CN¥748.16 Million | CN¥313.63 Million | CN¥49.56 Million | ▲ +872.0% |
| 2024 | 0.25x | CN¥69.99 Million | CN¥285.19 Million | CN¥67.32 Million | ▼ -59.0% |
| 2023 | 0.60x | CN¥179.11 Million | CN¥299.02 Million | CN¥88.61 Million | ▼ -20.6% |
| 2022 | 0.75x | CN¥197.53 Million | CN¥261.89 Million | CN¥99.19 Million | ▲ +65.0% |
| 2021 | 0.46x | CN¥146.69 Million | CN¥320.96 Million | CN¥127.74 Million | ▼ -76.3% |
| 2020 | 1.93x | CN¥471.61 Million | CN¥244.35 Million | CN¥91.72 Million | ▼ -17.5% |
| 2019 | 2.34x | CN¥564.98 Million | CN¥241.49 Million | CN¥122.95 Million | ▲ +80.1% |
| 2018 | 1.30x | CN¥168.98 Million | CN¥130.08 Million | CN¥128.13 Million | ▼ -48.4% |
| 2017 | 2.52x | CN¥176.96 Million | CN¥70.27 Million | CN¥83.02 Million | ▼ -32.9% |
| 2016 | 3.75x | CN¥538.92 Million | CN¥143.67 Million | CN¥269.85 Million | ▼ -90.8% |
| 2015 | 40.66x | CN¥332.43 Million | CN¥8.17 Million | CN¥128.70 Million | ▲ +14791.4% |
| 2014 | 0.27x | CN¥60.47 Million | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥70.43 Million | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥55.56 Million | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥14.81 Million | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥5.22 Million | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥17.32 Million | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥20.32 Million | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥17.92 Million | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥47.67 Million | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥57.55 Million | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥27.23 Million | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥36.08 Million | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥8.58 Million | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥8.76 Million | CN¥4.13 Million | CN¥8.76 Million | — |